Jose Seijas-Amigo

Clinical Benefit of Bempedoic Acid in Randomized Clinical Trials.

J. Badimón, J. Castellano, L. Fácila, 2023, American Journal of Cardiology.

Prevention of myocardial infarction and stroke with PCSK9 inhibitors treatment: a metanalysis of recent randomized clinical trials

J. González-Juanatey, L. Fácila, A. Cordero, 2020, Journal of Diabetes & Metabolic Disorders.

Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID‐REAL registry

J. González-Juanatey, L. Fácila, J. Bañeras, 2022, European journal of clinical investigation.

Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry

J. González-Juanatey, L. Fácila, J. Bañeras, 2021, Journal of cardiovascular pharmacology.

Observational multicentre prospective study to assess changes in cognitive function in patients treated with PCSK9i. Study protocol.

J. González-Juanatey, A. Estany-Gestal, M. Santamaría-Cadavid, 2021, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Estimation of the major cardiovascular events prevention with Inclisiran.

J. Badimón, J. Núñez, J. González-Juanatey, 2020, Atherosclerosis.

Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase.

J. González-Juanatey, A. Cordero, Á. Salgado-Barreira, 2023, Primary care diabetes.

Effect of dapagliflozin on COVID-19 infection and risk of hospitalization

A. Figueiras, S. Eiras, M. Rodríguez-Mañero, 2023, The Journal of antimicrobial chemotherapy.

Semaglutide versus GLP-1 agonists. Effectiveness, safety, and quality of life in patients with diabetes mellitus 2. The SEVERAL study.

J. González-Juanatey, M. Rodríguez-Mañero, Á. Salgado-Barreira, 2022, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

J. Rodríguez-Sánchez, A. Estany-Gestal, L. Margusino-Framiñán, 2023, American Journal of Cardiovascular Drugs.